Welcome to Paid Research Studies




  • Condition:   Testicular Cancer
    Intervention:  
    Sponsor:   University Medical Center Groningen
    Recruiting

  • Condition:   Testicular Cancer
    Interventions:   Other: WATChmAN Active Surveillance;   Other: In-person Active Surveillance
    Sponsor:   University Health Network, Toronto
    Recruiting

  • Condition:   Testicular Cancer
    Interventions:   Drug: Androgel (Testosterone gel);   Drug: Placebo gel
    Sponsor:   University Medical Center Groningen
    Recruiting

  • Condition:   Testicular Cancer
    Intervention:  
    Sponsor:   National Cancer Institute (NCI)
    Recruiting

  • Condition:   Testicular Neoplasms
    Intervention:  
    Sponsors:   Dr. med. Christian Rothermundt;   German Testicular Cancer Study Group
    Recruiting

  • Condition:   Testicular Cancer
    Interventions:   Drug: Veliparib;   Drug: Gemcitabine;   Drug: Carboplatin
    Sponsor:   National Cancer Institute, Slovakia
    Recruiting

  • Condition:   Testicular Neoplasm
    Intervention:   Diagnostic Test: MRI with DWI vs CT
    Sponsor:   Aarhus University Hospital
    Recruiting

  • Condition:   Testicular Cancer
    Intervention:  
    Sponsor:   University Medical Center Groningen
    Recruiting

  • Conditions:   Testicular Neoplasms;   Seminoma
    Interventions:   Drug: Bleomycin Etoposide and Cisplatin;   Drug: Carboplatin
    Sponsors:   St. Olavs Hospital;   Skane University Hospital;   Haukeland University Hospital;   University Hospital of North Norway;   Sahlgrenska University Hospital, Sweden;   Karolinska Institutet;   Oslo University Hospital;   Uppsala University Hospital;   University Hospital, Linkoeping;   Norrlands University Hospital
    Recruiting

  • Condition:   Testicular Cancer
    Intervention:   Drug: cabazitaxel
    Sponsors:   University Hospital, Akershus;   Sanofi
    Recruiting

  • Conditions:   Testis Cancer;   Cognitive Impairment;   Sexual Dysfunction
    Intervention:  
    Sponsor:   University of Aarhus
    Recruiting

  • Conditions:   Germ Cell Tumor;   Testicular Tumor
    Interventions:   Behavioral: Questionnaires;   Other: sample of blood or saliva
    Sponsor:   Memorial Sloan Kettering Cancer Center
    Recruiting

  • Conditions:   Seminoma;   Testicular Cancer
    Interventions:   Drug: Carboplatin;   Drug: Cisplatin;   Drug: Etoposide
    Sponsors:   Swiss Group for Clinical Cancer Research;   German Testicular Cancer Study Group
    Recruiting

  • Conditions:   Adenocarcinoma;   Adenocystic Carcinoma;   Anal Cancer;   Appendix Cancer;   Brain Tumor;   Glioblastoma;   Astrocytoma;   Bile Duct Cancer;   Cholangiocarcinoma;   Bladder Cancer;   Bone Cancer;   Synovial Sarcoma;   Chondrosarcoma;   Liposarcoma;   Sarcoma, Kaposi;   Sarcoma,Soft Tissue;   Sarcoma;   Osteosarcoma;   CNS Cancer;   Brain Stem Neoplasms;   Breast Cancer;   Cervical Cancer;   Colorectal Cancer;   Rectal Cancer;   Colon Cancer;   Esophageal Cancer;   Esophagus Cancer;   Cancer of Colon;   Pancreatic Cancer;   Cancer of Pancreas;   Testis Cancer;   Testicular Cancer;   Ureter Cancer;   Renal Cell Carcinoma;   Kidney Cancer;   Gestational Trophoblastic Tumor;   Head and Neck Neoplasms;   Parotid Tumor;   Larynx Cancer;   Tongue Cancer;   Pharynx Cancer;   Salivary Gland Cancer;   Acute Myeloid Leukemia;   Chronic Myeloid Leukemia;   Acute Lymphoblastic Leukemia;   Multiple Myeloma;   Non Hodgkin Lymphoma;   Carcinoid Tumor;   Lung Cancer;   Pulmonary Candidiasis;   Neuroendocrine Tumors;   Mesothelioma;   Thyroid Cancer;   Parathyroid Neoplasms;   Adrenal Cancer;   Small Bowel Cancer;   Stomach Cancer;   Liver Cancer;   Hepatic Cancer;   Melanoma;   Skin Cancer;   Unknown Primary Tumors;   Uterine Cancer;   Fallopian Tube Cancer;   Ovarian Cancer;   Prostate Cancer;   Vaginal Cancer;   Penile Cancer;   Vulvar Cancer;   Waldenstrom Macroglobulinemia;   Cancer, Advanced;   Thymus Cancer;   Nasopharyngeal Carcinoma;   Multiple Endocrine Neoplasia;   Pheochromocytoma;   Small Cell Carcinoma
    Interventions:   Diagnostic Test: Testing: Genome;   Diagnostic Test: Testing: Transcriptome;   Diagnostic Test: Testing: Proteome;   Drug: Treatment: CAR-T
    Sponsor:   Taproot Health
    Not yet recruiting

  • Conditions:   Cancer, All Types;   Cancer of Liver;   Cancer of Stomach;   Cancer of Head and Neck;   Cancer of Rectum;   Cancer of Kidney;   Cancer of Esophagus;   Cancer of Colon;   Cancer Skin;   Cancer of Cervix;   Cancer, Metastatic;   Cancer of Larynx;   Cancer of Neck;   Cancer of Lung;   Cancer of Brain and Nervous System;   Cancer of Vulva, Disseminated;   Cancer of Pancreas;   Sarcoma;   GIST;   Small-cell Lung Cancer;   Adenocarcinoma Lung;   Cancer of Prostate;   Cancer, Advanced;   Adrenal Cancer;   Testicular Cancer;   Uterine Cancer;   Bronchoalveolar Cell Lung Cancer;   Cancer Unknown Primary;   Glioblastoma Multiforme;   Oligodendroglioma;   Breast Cancer;   Renal Cell Carcinoma;   Hepatocellular Carcinoma;   Cholangiocarcinoma;   Squamous Cell Carcinoma;   Transitional Cell Carcinoma;   Cancer, Other;   Cancer, Anal;   Melanoma;   Cancer, Bile Duct;   Cancer, Bladder;   Cancer Cords Vocal;   Cancers Cell Neuroendocrine;   Cancer Differentiated Poorly;   Cancer, Anaplastic Thyroid
    Intervention:  
    Sponsors:   SpeciCare;   Dana-Farber Cancer Institute;   Kalispell Regional Medical Center;   Georgia Institute of Technology;   Ontario Institute for Cancer Research;   SEngine Precision Medicine;   Helomics
    Recruiting

  • Conditions:   Cancer, Metastatic;   Cancer;   Cancer of Pancreas;   Cancer of Liver;   Cancer of Stomach;   Cancer Liver;   Cancer of Rectum;   Cancer of Kidney;   Cancer of Esophagus;   Cancer of Cervix;   Cancer of Colon;   Cancer of Larynx;   Cancer, Lung;   Cancer, Breast;   Cancer, Advanced;   Cancer Prostate;   Cancer of Neck;   Cancer of Skin;   Neuroendocrine Tumors;   Carcinoma;   Mismatch Repair Deficiency;   BRCA Gene Rearrangement;   Non Hodgkin Lymphoma;   Leukemia;   Non Small Cell Lung Cancer;   Cholangiocarcinoma;   Glioblastoma;   Central Nervous System Tumor;   Melanoma;   Urothelial Carcinoma;   Bladder Cancer;   Ovarian Cancer;   Endometrial Cancer;   Testicular Cancer;   Breast Cancer
    Intervention:   Other: Clinical Trial Matching
    Sponsor:   Massive Bio, Inc.
    Recruiting

  • Conditions:   Head and Neck Squamous Cell Carcinoma;   Breast Cancer;   Sarcoma;   Merkel Cell Carcinoma;   Cutaneous T-Cell Lymphoma;   Melanoma;   Renal Cancer;   Bladder Cancer;   Prostate Cancer;   Testicular Cancer;   Solid Tumor
    Interventions:   Drug: Durvalumab;   Drug: Tremelimumab;   Drug: Poly ICLC
    Sponsors:   Ludwig Institute for Cancer Research;   MedImmune LLC;   Cancer Research Institute, New York City
    Recruiting

  • Conditions:   Pancreatic Cancer;   Thyroid Cancer;   Lung Cancer;   Esophageal Cancer;   Thymus Cancer;   Colon Cancer;   Rectal Cancer;   GIST;   Anal Cancer;   Bile Duct Cancer;   Duodenal Cancer;   Gallbladder Cancer;   Gastric Cancer;   Liver Cancer;   Small Intestine Cancer;   Peritoneal Surface Malignancies;   Familial Adenomatous Polyposis;   Lynch Syndrome;   Bladder Cancer;   Kidney Cancer;   Penile Cancer;   Prostate Cancer;   Testicular Cancer;   Ureter Cancer;   Urethral Cancer;   Hypopharyngeal Cancer;   Laryngeal Cancer;   Lip Cancer;   Oral Cavity Cancer;   Nasopharyngeal Cancer;   Oropharyngeal Cancer;   Paranasal Sinus Cancer;   Nasal Cavity Cancer;   Salivary Gland Cancer;   Skin Cancer;   CNS Tumor;   CNS Cancer;   Mesothelioma;   Breast Cancer;   Leukemia;   Melanoma;   Sarcoma;   Unknown Primary Tumor;   Multiple Myeloma;   Ovarian Cancer;   Endometrial Cancer;   Vaginal Cancer;   Neuroendocrine Tumors;   Plasma Cell Dyscrasia
    Intervention:  
    Sponsor:   University of Nebraska
    Recruiting

  • Conditions:   Radiation Therapy;   Cancer;   Cancer of Anus;   Cancer of Bladder;   Cancer of Cervix;   Cancer of Colon;   Cancer of Rectum;   Cancer of Esophagus;   Cancer of Gallbladder;   Cancer of Liver;   Cancer of Ovary;   Cancer of Pancreas;   Cancer of Prostate;   Cancer of Kidney and Renal Pelvis;   Cancer of Stomach;   Cancer of Testis;   Cancer of Uterus;   Cancer of Uterus and Cervix;   Cancer of Kidney
    Intervention:  
    Sponsors:   DxTerity Diagnostics;   National Cancer Institute (NCI)
    Recruiting

  • Condition:   Germ Cell Tumor
    Interventions:   Drug: Durvalumab;   Drug: Tremelimumab
    Sponsors:   Fondazione IRCCS Istituto Nazionale dei Tumori, Milano;   AstraZeneca
    Recruiting

  • Condition:   Cancer-related Cognitive Impairment
    Intervention:  
    Sponsors:   University of Aarhus;   Aarhus University Hospital
    Recruiting

  • Conditions:   Bladder Adenocarcinoma;   Bladder Mixed Adenocarcinoma;   Bladder Small Cell Carcinoma;   Bladder Squamous Cell Carcinoma;   Bone Lesion;   Chromophobe Renal Cell Carcinoma;   Infiltrating Bladder Lymphoepithelioma-Like Carcinoma;   Infiltrating Bladder Urothelial Carcinoma;   Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant;   Infiltrating Bladder Urothelial Carcinoma With Giant Cells;   Infiltrating Bladder Urothelial Carcinoma, Nested Variant;   Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant;   Kidney Medullary Carcinoma;   Large Cell Neuroendocrine Carcinoma;   Metastatic Bladder Carcinoma;   Metastatic Bladder Large Cell Neuroendocrine Carcinoma;   Metastatic Bladder Small Cell Carcinoma;   Metastatic Bladder Squamous Cell Carcinoma;   Metastatic Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant;   Metastatic Infiltrating Bladder Urothelial Carcinoma, Lipid-Rich Variant;   Metastatic Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant;   Metastatic Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant;   Metastatic Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant;   Metastatic Kidney Medullary Carcinoma;   Metastatic Malignant Genitourinary System Neoplasm;   Metastatic Penile Carcinoma;   Metastatic Prostate Small Cell Carcinoma;   Metastatic Sarcomatoid Renal Cell Carcinoma;   Papillary Renal Cell Carcinoma;   Sarcomatoid Renal Cell Carcinoma;   Stage IV Bladder Cancer AJCC v8;   Stage IV Penile Cancer AJCC v8;   Stage IV Prostate Cancer AJCC v8;   Stage IV Renal Cell Cancer AJCC v8;   Stage IVA Bladder Cancer AJCC v8;   Stage IVA Prostate Cancer AJCC v8;   Stage IVB Bladder Cancer AJCC v8;   Stage IVB Prostate Cancer AJCC v8;   Testicular Leydig Cell Tumor;   Testicular Sertoli Cell Tumor
    Interventions:   Drug: Cabozantinib;   Drug: Cabozantinib S-malate;   Biological: Ipilimumab;   Biological: Nivolumab
    Sponsor:   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Childhood Germ Cell Tumor;   Ovarian Cancer;   Teratoma
    Interventions:   Drug: carboplatin;   Drug: etoposide;   Drug: ifosfamide;   Drug: paclitaxel;   Drug: thiotepa;   Procedure: autologous hematopoietic stem cell transplantation;   Drug: Mesna;   Biological: filgrastim
    Sponsor:   Masonic Cancer Center, University of Minnesota
    Recruiting

  • Conditions:   Ovarian Granulosa Cell Tumor;   Ovarian Gynandroblastoma;   Ovarian Sertoli-Leydig Cell Tumor;   Ovarian Sex Cord Tumor With Annular Tubules;   Ovarian Sex Cord-Stromal Tumor;   Ovarian Sex Cord-Stromal Tumor of Mixed or Unclassified Cell Types;   Ovarian Steroid Cell Tumor
    Interventions:   Biological: Bleomycin Sulfate;   Drug: Carboplatin;   Drug: Cisplatin;   Drug: Etoposide Phosphate;   Other: Laboratory Biomarker Analysis;   Drug: Paclitaxel
    Sponsors:   Gynecologic Oncology Group;   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Pleuropulmonary Blastoma;   Cystic Nephroma;   Ovarian Sertoli-Leydig Cell Tumors;   Ocular Medulloepithelioma;   Nasal Chondromesenchymal Hamartoma
    Intervention:  
    Sponsor:   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Pleuropulmonary Blastoma;   Sertoli-Leydig Cell Tumor;   DICER1 Syndrome;   Cystic Nephroma;   Wilms Tumor;   Pineoblastoma;   Renal Sarcoma;   Nodular Hyperplasia of Thyroid;   Nasal Chondromesenchymal Hamartoma;   Ciliary Body Medulloepithelioma;   Neuroblastoma;   Pituitary Cancer;   Embryonal Rhabdomyosarcoma
    Intervention:  
    Sponsors:   Children's Hospitals and Clinics of Minnesota;   Children's Research Institute;   Washington University School of Medicine;   ResourcePath, LLC;   Beijing Children's Hospital;   University of Cambridge;   Emory University;   Dana-Farber Cancer Institute
    Recruiting

  • Condition:   Germ Cell Cancer
    Intervention:  
    Sponsor:   Rigshospitalet, Denmark
    Recruiting

  • Condition:   Testicular Germ Cell Tumor
    Intervention:  
    Sponsors:   Royal Marsden NHS Foundation Trust;   University College London (UCL) Cancer Institute
    Recruiting

  • Conditions:   Ovarian Stromal Tumor;   Testicular Stromal Tumors;   Ovarian Small Cell Carcinoma;   DICER1 Gene Mutation
    Intervention:  
    Sponsors:   Children's Hospitals and Clinics of Minnesota;   Children's Research Institute;   Dana-Farber Cancer Institute;   Washington University School of Medicine;   University of Texas Southwestern Medical Center;   M.D. Anderson Cancer Center;   Children's Hospital Colorado;   Rutgers University;   Massachusetts General Hospital;   Klinikum Dortmund Wirbelsäulenchirurgie;   ResourcePath, LLC
    Recruiting

  • Conditions:   Childhood Cancer;   Fertility Disorders
    Intervention:   Procedure: testicular tissue biopsy
    Sponsor:   Gumy-Pause Fabienne
    Recruiting

  • Condition:   Cancer
    Intervention:   Procedure: Testicular tissue cryopreservation
    Sponsor:   Mayo Clinic
    Recruiting